Fajardo Calderón, C. A. (2017). Arming oncolytic adenoviruses with bi-specific T-cell engagers to improve antitumor efficacy.
Citación estilo ChicagoFajardo Calderón, Carlos Alberto. Arming Oncolytic Adenoviruses With Bi-specific T-cell Engagers to Improve Antitumor Efficacy. 2017.
Cita MLAFajardo Calderón, Carlos Alberto. Arming Oncolytic Adenoviruses With Bi-specific T-cell Engagers to Improve Antitumor Efficacy. 2017.
Precaución: Estas citas no son 100% exactas.